LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
5 FTSE stocks Fools think will lead the next bull market charge
Investing Articles
Up 38% from its 12-month low, how can AstraZeneca’s share price still look cheap?
Investing Articles
AstraZeneca hits £200bn as its share price soars. Can I afford to miss out?
Investing Articles
If I had £5k to invest in August, I’d buy these 2 top FTSE 100 stocks
Investing Articles
No savings at 40? I’d buy cheap UK shares to retire richer
Investing Articles
AstraZeneca, a mega-cap growth stock that just got cheaper!
Investing Articles
The AstraZeneca share price dips as the company raises full-year guidance!
Investing Articles
Here’s why H1 results could boost the AstraZeneca share price
Investing Articles
As AstraZeneca’s share price dips 4%, is it time for me to buy more?
Investing Articles
The AstraZeneca share price is up 88% in 5 years, but is it just getting started?
Investing Articles
Here’s Buffett’s ‘secret sauce’ to finding the best UK shares to buy today